Kimia Biosciences
KIMIABL · Pharma > Pharmaceuticals & Drugs Listing date: May 23, 2016

Stock Price vs Company Growth
1d
2.3%
1w
3.8%
1m
10.2%
3m
3.6%
6m
5.4%
1y
54.8%
5y
8.3%
all
19.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 30.8 2.3%
30.8
40
Company Overview

Sales
115 Cr
Growth: 7.5%
Profit after Tax
7.43 Cr
Growth: -17.9%
Micro Cap
146 Cr
P/E: 18.8x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 115
Growth 7.5%
EBITDA 12.4%
P/S 1.3x
Dividend 0.0%
P/E 18.8x
Book Value ₹ 3.67
PEG Ratio 2.6x
ROE 52.6%
P/B 8.6x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

:The company is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.
Investors (2)